$TOMZ

TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Revenue of $2.5 Million, Up 27% Year-Over-Year

TOMI Environmental Solutions (TOMZ) reported preliminary Q3 2026 revenue of $2.5M, up 27% YoY. The company expects Q4 revenue of $1.7M and a full-year target of $12M. All product lines showed growth, with services up 77% and automated projects up 330% YoY. The open order book stands at $2.5M, up from $2.2M in Q2.

Original reporting
Published Oct 8, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 12:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Revenue of $2.5 Million, Up 27% Year-Over-Year — source image
Decision brief

The 30-second read

$TOMZBullishMed
01

Why it matters

The update provides a near-term expectation set for Q3 performance (revenue growth, sequential improvement, gross margin expectation) and indicates Q4 has $1.7M already booked, with an open order book of $2.5M.

02

Market read

Traders can reassess near-term expectations for TOMZ’s upcoming Q3 10-Q and Q4 profitability trajectory based on the preliminary revenue, backlog, and gross margin expectation.

03

What to watch

The article emphasizes backlog and booked Q4 revenue, but does not quantify cash flow, customer concentration, or the durability of demand beyond the stated order book.

Relevance 6/10Novelty 5/10Timing: pre-market today ahead of the company’s full Q3 10-Q

Background

TOMZ is a disinfection and decontamination company selling SteraMist iHP products and services built on its Binary Ionization Technology platform.

Company-level read

Ticker impact

$TOMZBullishMedium confidence
Context

TOMZ reports preliminary Q3 2026 revenue of $2.5M, up 27% YoY, with sequential revenue up 13% and gross margin expected to exceed Q2.

Expected impact

Likely upward bias as traders price in stronger Q3 performance and a potentially profitable Q4 trajectory.

Evidence & confidence

The release provides fresh, company-specific quarterly datapoints (revenue, backlog/order book, Q4 booked amount, gross margin expectation) that can move expectations before the formal 10-Q.

Market effects

Signals demand strength in disinfection and decontamination solutions, but impact is likely limited to the single issuer given the small scale.

No clear regional spillover beyond US small-cap biotech/industrial disinfectant peers.

Limited global relevance; the update is company-specific with no broader industry shock described.

Counterpoint

Preliminary figures may change materially in the 10-Q, so the market could fade the update if final revenue recognition or margin differs.

Key entities

  • TOMI Environmental Solutions, Inc.

    NASDAQ-listed disinfection and decontamination company issuing preliminary Q3 2026 sales and backlog update.

  • E.J. Shane

    Chief Operating Officer quoted on continued demand and Q4 booking.

  • Dr. Halden Shane

    CEO and Chairman quoted on profitability expectations and merger-candidate evaluation.

Related articles

$TOMZHighAI 8/10

Tomi Environmental stock surges on canceled merger deal

Tomi Environmental Solutions Inc (TOMZ) shares rose 15% after-hours Monday after terminating its merger agreement with Carbonium Core Inc. The companies agreed the deal was no longer strategically or financially beneficial. CEO Dr. Halden Shane cited strong business performance and focus on shareholder value. TOMZ provides disinfection and decontamination solutions.

$TOMZMed

TOMI Environmental Solutions, Inc. Reports Second Quarter 2026 Financial Results

TOMI Environmental Solutions, Inc. (TOMZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 FOR IMMEDIATE RELEASE TOMI Environmental Solutions, Inc. Reports Second Quarter 2026 Financial Results Company Delivers 118% Q2 Revenue Growth, Reaffirms Full-Year 2026 Guidance of $12 Million (113% YoY Growth) FREDERICK, Md., August 14, 2026 (GLOBE NEWSWIRE) -- TOMI

$TOMZMed

TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages

TOMI Environmental Solutions, Inc. (TOMZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages -Carbonium Merger Remains on Track -European Regulatory Expansion and Partnership Growth -Advancement of B

$TOMZMed

TOMI Environmental Solutions, Inc.: TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages

TOMI Environmental Solutions (NASDAQ: TOMZ) reaffirmed fiscal 2026 revenue guidance of at least $12 million and said it has a $35 million sales pipeline, including about $8.6 million in advanced stages. The company reported booked orders of $6.2 million and Q2 growth across key metrics. TOMI also said its Carbonium merger remains on track for H2 2026.

$TOMZMedAI 8/10

TOMI Reports 124% Increase in Preliminary Second Quarter Revenue; Preliminary Six Months Revenue Combined with Open Orders Surpass Full Year 2025 Revenue

TOMI Environmental Solutions (NASDAQ: TOMZ) reported preliminary Q2 2026 revenue of about $2.3 million, up 124% year over year, and said open orders of $6.2 million already exceed full-year 2025 revenue. It cited higher revenue across equipment, accessories, support services, applicators, and BIT Solution, with gross margin at 70%.

$TOMZMedAI 9/10

Global Norovirus Outbreaks, Ebola Emergency and Rising Disease Threats Highlight Growing Need for TOMI Environmental Solutions' SteraMist Technology

TOMI Environmental Solutions (NASDAQ: TOMZ) said NASA selected its SteraMist ionized hydrogen peroxide (iHP) technology for a Mars Sample Return biosecurity operation. The company also cited rising infectious-disease alerts, including norovirus outbreaks and Ebola-related concerns, as driving demand for scalable disinfection in hospitals, hotels, cruise lines, schools and government sites.